Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical threshold.
Bsteh G, Hegen H, Krajnc N, Föttinger F, Altmann P, Auer M, Berek K, Kornek B, Leutmezer F, Macher S, Monschein T, Ponleitner M, Rommer P, Schmied C, Zebenholzer K, Zulehner G, Zrzavy T, Deisenhammer F, Di Pauli F, Pemp B, Berger T. Bsteh G, et al. Among authors: zebenholzer k. Ann Clin Transl Neurol. 2024 Dec 16. doi: 10.1002/acn3.52279. Online ahead of print. Ann Clin Transl Neurol. 2024. PMID: 39686570 Free article.
Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score.
Bsteh G, Hegen H, Riedl K, Altmann P, Auer M, Berek K, Di Pauli F, Ehling R, Kornek B, Monschein T, Rinner W, Schmied C, Wurth S, Zebenholzer K, Zinganell A, Zrzavy T, Zulehner G, Deisenhammer F, Rommer P, Leutmezer F, Berger T. Bsteh G, et al. Among authors: zebenholzer k. Eur J Neurol. 2021 May;28(5):1609-1616. doi: 10.1111/ene.14705. Epub 2021 Jan 18. Eur J Neurol. 2021. PMID: 33370478 Free PMC article.
Retinal layer thickness predicts disability accumulation in early relapsing multiple sclerosis.
Bsteh G, Hegen H, Altmann P, Auer M, Berek K, Di Pauli F, Haider L, Kornek B, Krajnc N, Leutmezer F, Macher S, Rommer P, Walchhofer LM, Zebenholzer K, Zulehner G, Deisenhammer F, Pemp B, Berger T. Bsteh G, et al. Among authors: zebenholzer k. Eur J Neurol. 2023 Apr;30(4):1025-1034. doi: 10.1111/ene.15718. Epub 2023 Feb 16. Eur J Neurol. 2023. PMID: 36719184
Retinal layer thinning for monitoring disease-modifying treatment in relapsing multiple sclerosis-Evidence for applying a rebaselining concept.
Bsteh G, Hegen H, Krajnc N, Föttinger F, Altmann P, Auer M, Berek K, Kornek B, Leutmezer F, Macher S, Monschein T, Ponleitner M, Rommer P, Schmied C, Zebenholzer K, Zulehner G, Zrzavy T, Deisenhammer F, Di Pauli F, Pemp B, Berger T. Bsteh G, et al. Among authors: zebenholzer k. Mult Scler. 2024 Aug;30(9):1128-1138. doi: 10.1177/13524585241267257. Epub 2024 Aug 7. Mult Scler. 2024. PMID: 39109593 Free article.
B Cell Depletion and SARS-CoV-2 Vaccine Responses in Neuroimmunologic Patients.
Kornek B, Leutmezer F, Rommer PS, Koblischke M, Schneider L, Haslacher H, Thalhammer R, Zimprich F, Zulehner G, Bsteh G, Dal-Bianco A, Rinner W, Zebenholzer K, Wimmer I, Steinmaurer A, Graninger M, Mayer M, Roedl K, Berger T, Winkler S, Aberle JH, Tobudic S. Kornek B, et al. Among authors: zebenholzer k. Ann Neurol. 2022 Mar;91(3):342-352. doi: 10.1002/ana.26309. Epub 2022 Feb 8. Ann Neurol. 2022. PMID: 35067959 Free PMC article.
Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple Sclerosis.
Bsteh G, Hegen H, Altmann P, Auer M, Berek K, Di Pauli F, Kornek B, Krajnc N, Leutmezer F, Macher S, Rommer PS, Zebenholzer K, Zulehner G, Zrzavy T, Deisenhammer F, Pemp B, Berger T; for VMSD (Vienna Multiple Sclerosis Database) Group. Bsteh G, et al. Among authors: zebenholzer k. Neurology. 2023 Aug 22;101(8):e784-e793. doi: 10.1212/WNL.0000000000207507. Epub 2023 Jul 3. Neurology. 2023. PMID: 37400245 Free PMC article.
Immunophenotyping in routine clinical practice for predicting treatment response and adverse events in patients with MS.
Zrzavy T, Rieder K, Wuketich V, Thalhammer R, Haslacher H, Altmann P, Kornek B, Krajnc N, Monschein T, Schmied C, Zebenholzer K, Zulehner G, Berger T, Rommer P, Leutmezer F, Bsteh G. Zrzavy T, et al. Among authors: zebenholzer k. Front Neurol. 2024 Apr 16;15:1388941. doi: 10.3389/fneur.2024.1388941. eCollection 2024. Front Neurol. 2024. PMID: 38689880 Free PMC article.
Iron Rims in Patients With Multiple Sclerosis as Neurodegenerative Marker? A 7-Tesla Magnetic Resonance Study.
Dal-Bianco A, Schranzer R, Grabner G, Lanzinger M, Kolbrink S, Pusswald G, Altmann P, Ponleitner M, Weber M, Kornek B, Zebenholzer K, Schmied C, Berger T, Lassmann H, Trattnig S, Hametner S, Leutmezer F, Rommer P. Dal-Bianco A, et al. Among authors: zebenholzer k. Front Neurol. 2021 Dec 21;12:632749. doi: 10.3389/fneur.2021.632749. eCollection 2021. Front Neurol. 2021. PMID: 34992573 Free PMC article.
Benefits of inpatient multidisciplinary rehabilitation in multiple sclerosis.
Salhofer-Polanyi S, Windt J, Sumper H, Grill H, Essmeister M, Diermayr G, Zebenholzer K, Leutmezer F, Zulehner G, Vass K, Asenbaum-Nan S. Salhofer-Polanyi S, et al. Among authors: zebenholzer k. NeuroRehabilitation. 2013;33(2):285-92. doi: 10.3233/NRE-130956. NeuroRehabilitation. 2013. PMID: 23949063 Clinical Trial.
48 results